Saumya Sutaria - 24 Aug 2026 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Aug 2026, 20:00:03 UTC
Prior SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Chad J. Wiener as Attorney-in-Fact for Saumya Sutaria
Filing notes and source

Key filing fact

Saumya Sutaria filed Form 4 for TENET HEALTHCARE CORP (THC) on 26 Aug 2026.

Key facts

  • This page summarizes Saumya Sutaria's Form 4 filing for TENET HEALTHCARE CORP (THC).
  • 5 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Aug 2026, 20:00.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: -$27,636,335.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001760857 Primary reporting owner

Sutaria Saumya

Relationship
CEO, Director
Address
14201 DALLAS PARKWAY, DALLAS
Signature
Chad J. Wiener as Attorney-in-Fact for Saumya Sutaria
Signature date
26 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

THC transaction

Common Stock

Sale

Transaction value
-$3,711,900
Shares
-13,344
Change %
-2.5%
Price
$278.17
Shares after
520,220
Date
24 Aug 2026
Ownership
Direct
Footnotes
F1, F2
THC transaction

Common Stock

Sale

Transaction value
-$10,223,358
Shares
-36,656
Change %
-7%
Price
$278.90
Shares after
483,564
Date
24 Aug 2026
Ownership
Direct
Footnotes
F2, F3
THC transaction

Common Stock

Sale

Transaction value
-$4,706,915
Shares
-17,220
Change %
-3.6%
Price
$273.34
Shares after
466,344
Date
25 Aug 2026
Ownership
Direct
Footnotes
F2, F4
THC transaction

Common Stock

Sale

Transaction value
-$6,819,882
Shares
-24,881
Change %
-5.3%
Price
$274.10
Shares after
441,463
Date
25 Aug 2026
Ownership
Direct
Footnotes
F2, F5
THC transaction

Common Stock

Sale

Transaction value
-$2,174,279
Shares
-7,899
Change %
-1.8%
Price
$275.26
Shares after
433,564
Date
25 Aug 2026
Ownership
Direct
Footnotes
F2, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $277.58 to $278.57.

Footnote F2

The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Footnote F3

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $278.59 to $279.14.

Footnote F4

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $272.65 to $273.64.

Footnote F5

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $273.65 to $274.64.

Footnote F6

The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $274.73 to $275.55.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .